SB 120-FN (2025): relative to insurance coverage for biomarker testing.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “SB 120-FN (2025): relative to insurance coverage for biomarker testing.” Granite Record, https://graniterecord.org/bill/2025/sb120. Accessed 19 Oct. 2026.
- APA
- Granite Record. (n.d.). SB 120-FN (2025): relative to insurance coverage for biomarker testing. Retrieved 19 Oct. 2026, from https://graniterecord.org/bill/2025/sb120
- Chicago
- Granite Record. “SB 120-FN (2025): relative to insurance coverage for biomarker testing.” Accessed 19 Oct. 2026. https://graniterecord.org/bill/2025/sb120.
- BibTeX
@misc{bill-2025-sb120, title = {SB 120-FN (2025): relative to insurance coverage for biomarker testing.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2025/sb120}, note = {Accessed 19 Oct. 2026} }
SB 120-FN (2025)
relative to insurance coverage for biomarker testing.
- Status: Died on the table
- Term: 2025-2026
- Senate committee: Health and Human Services
- Subject: Insurance
The Story
It was introduced on January 9, 2025 and referred to the Senate Health and Human Services committee. The committee held a public hearing on January 29, 2025. The committee voted unanimously, 5–0, to recommend that the Senate pass it with changes (amendment 2025-0554s), and the report was placed on the consent calendar. The bill was taken off the consent calendar on March 6, 2025. The committee's amendment (2025-0554s) was adopted on a voice vote on March 6, 2025, changing the text of the bill. On March 6, 2025 the Senate adopted the motion that it ought to pass with an amendment on a voice vote, but its third reading was left pending. On March 6, 2025 the Senate voted to lay it on the table on a voice vote, on a motion by Sen. Regina Birdsell. The bill died on the table under Senate Rule 3-23 on October 31, 2025, having been set aside and never taken back up.
Sponsors
- Sen. Daniel Innis (R - SD7) (prime sponsor)
- Sen. Suzanne Prentiss (D - SD5)
- Rep. John Potucek (R - Rock 13)
- Sen. David Watters (D - SD4)
- Sen. Cindy Rosenwald (D - SD13)
- Rep. Mary Jane Wallner (D - Merr 19)
Hearings and Sessions
- January 29, 2025, 9:45 AM: hearing, Senate Health and Human Services, LOB 101
- March 6, 2025: floor debate, Senate
Votes
- March 6, 2025, Senate: Ought to Pass with Amendment #2025-0554s — voice vote, passed
- March 6, 2025, Senate: Laid on Table — voice vote, passed
The Docket
- January 9, 2025: Introduced 01/09/2025 and Referred to Health and Human Services
- January 29, 2025: Hearing: 01/29/2025, Room 101, LOB, 09:45 am
- March 6, 2025: Committee Report: Ought to Pass with Amendment # 2025-0554s, 03/06/2025; Vote 5-0; CC
- March 6, 2025: SB 120 was Removed from the Consent Calendar; 03/06/2025
- March 6, 2025: Committee Amendment # 2025-0554s, AA, VV; 03/06/2025
- March 6, 2025: Ought to Pass with Amendment #2025-0554s, MA, VV; 03/06/2025
- March 6, 2025: Sen. Birdsell Moved Laid on Table, MA, VV; 03/06/2025
- March 6, 2025: Pending Motion OT3rdg; 03/06/2025
- October 31, 2025: Inexpedient to Legislate, Senate Rule 3-23, 10/31/2025
Laws It Would Change
Related Bills
- HB 2-FN-A-LOCAL (2025): relative to state fees, funds, revenues, and expenditures.
- SB 606-FN (2026): relative to insurance coverage for biomarker testing.